Image
Collaborative Care™

Comprehensive Cancer Pain Management

Let’s Talk Constipation

 

This activity is jointly provided by Global Education Group and Integritas Communications.

This activity is supported by an educational grant from AstraZeneca.

Target Audience

The educational design of this activity addresses the needs of oncology nurses, medical oncologists, and other clinicians involved in the treatment of patients with opioid-induced constipation (OIC).

Program Description

Despite the growing number of options to treat constipation symptoms, many patients with cancer pain suffer the burden of OIC. Patients are often reluctant to discuss symptoms of constipation, underscoring the need for clinicians to provide ongoing education on the signs and symptoms of OIC as well as the need to monitor bowel patterns at each visit. A collaborative, team-based approach that utilizes shared decision making to address patients’ unique preferences regarding OIC treatment is another critical aspect of care. During this Collaborative Care™ session, a multidisciplinary panel of expert faculty will review and discuss individualized management plans for OIC in patients with cancer pain. Pre-recorded patient simulation videos will be utilized to help guide attendees through proper OIC assessment with validated clinical tools, the initiation and escalation of appropriate therapies with respect to updated evidence-based guidelines, and effective patient communication strategies for discussing opioid-related bowel issues and available treatment options. Additionally, attendees will receive access to the online Clinical Resource Center™; an up-to-date web source for clinicians that provides the latest information in OIC care as well as patient education materials.

Learning Objectives

Upon completion of this activity, the participant should be better able to:

  • Evaluate baseline and ongoing bowel patterns in patients with opioid-treated cancer pain
  • Discuss the clinical profiles and guideline recommendations for US Food and Drug Administration (FDA)-approved treatment options for opioid-induced constipation (OIC)
  • Recommend bowel regimens for patients with opioid-treated cancer pain who do not respond to traditional laxative therapy
  • Engage with patients with opioid-treated cancer pain to facilitate bowel assessment efforts and shared decision-making about OIC therapies

Agenda

6:00–6:10 PM Preactivity Questionnaire and Faculty Introductions
6:10–6:25 PM OIC Pathophysiology With 3D Animation
6:25–6:50 PM Assessing Patients for OIC
6:50–7:15 PM Treatment of OIC
7:15–7:30 PM Postactivity Questionnaire and Q&A Session

Physician Accreditation Statement

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of Global Education Group (Global) and Integritas. Global is accredited by the ACCME to provide continuing medical education for physicians.

Physician Credit Designation

Global Education Group designates this live activity for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nursing Continuing Education

Global Education Group is accredited with distinction as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

This educational activity for 1.5 contact hours is provided by Global Education Group. Nurses should claim only the credit commensurate with the extent of their participation in the activity.

Fee Information

There is no registration fee for attending this program, however, seating is limited. Preregistration does not guarantee seating. We recommend arriving at the symposium location early.

Americans With Disability Act

Event staff will be glad to assist you with any special needs (ie, physical, dietary, etc). Please contact us prior to the live event at info@exchangecme.com.

Meeting space has been assigned to provide a Symposium supported by AstraZeneca during the Oncology Nursing Society’s (ONS) 44th Annual Congress, April 11-14, 2019 in Anaheim, CA. The oncology Nursing Society’s assignment of meeting space does not imply product endorsement.

Register Now


Full Name *
Credentials *
Phone
You may receive up to 4 messages per live event. Terms & Privacy Policy can be found below.
Message and data rates may apply. Reply STOP to end or HELP for help.
Primary Specialty

By clicking Register, you accept our Privacy Policy.